As Featured In:
VC Advisory and Execution Support
We help secure your life science investments through independent scientific due diligence, with post-investment support where needed.
Our assessments focus on scientific robustness, technical and regulatory feasibility, and the identification and resolution of critical gaps.
Early-stage biotech advisory
We partner with start-ups and spin-off to ensure funding-readiness and product viability on the pharmaceutical market.
We provide training, knowledge transfer and strategic support in quality assurance and GxP compliance to align regulatory requirements with practical, fast workflows, to ensure funding-readiness and real-world viability.
What makes us unique
Bringing life science innovations to the market faster, requires efficient navigation between very different worlds:
- Early scientific development, where experimental strategies evolve and the robustness and validity of data still need sufficient proof.
- The fast-moving reality of start-ups and AI-driven innovations, where new ventures and technologies must develop at high-speed.
- The regulated pharmaceutical markets, where products ultimately need to meet strict requirements, while maintaining practibility.
With hands-on experience across all these environments, Science2Capital supports informed investment decisions, robust development strategies and the translation of innovation into real-world applications, enabling faster and more reliable paths to the market.
How we work
As an agile team combining expertise across the product lifecycle of diverse life science technologies, we quickly form a comprehensive view of emerging innovations while avoiding critical blind spots.
Our evaluations follow a structured and standardized methodology designed to assess early-stage technologies in a consistent and comparable way across different projects.
The process combines evidence analysis, including systematic review of scientific literature, available data and methodological consistency, and with hands-on expert assessment and on-site insight where relevant.
This allows us to evaluate the core dimensions that determine the potential of an early-stage technology:
Scientific validity
Robust scientific foundations, reproducible data and sound experimental design.
Development readiness
A credible development strategy and realistic pathway toward scaling.
Regulatory feasibility
The ability of a technology to operate and evolve within regulated environments.
Testimonials
Christine Walters
My Story
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident.
Sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis.
